Moneycontrol PRO
tatva chintan pharma chem
Jump to
22 Results Found
  • Tatva Chintan sees best listing day gains of 2021, jumps 113.32% to close at Rs 2,310.25 Jul 29, 2021 05:43 PM IST

    Tatva Chintan sees best listing day gains of 2021, jumps 113.32% to close at Rs 2,310.25

    Tatva Chintan traded with volumes of 78.60 lakh equity shares on the NSE and 8.99 lakh shares on the BSE

  • Tatva Chintan doubles investors money on debut, what should investors do now? Jul 29, 2021 12:54 PM IST

    Tatva Chintan doubles investors money on debut, what should investors do now?

    Tatva Chintan Pharma Chem IPo shares gained more than 100 percent in one of the strongest listings in 2021. GR Infraprojects rallied 108.7 percent and Indigo Paints climbed 109.31 percent on listing day

  • Tatva Chintan shares debut at Rs 2,111.80, rising as much as 130% Jul 29, 2021 10:00 AM IST

    Tatva Chintan shares debut at Rs 2,111.80, rising as much as 130%

    Tatva Chintan IPO was subscribed 180.35 times. The specialty chemical company will utilise net proceeds from its fresh issue to expand its manufacturing facility in Dahej and upgrade the R&D facility in Vadodara

  • Tatva Chintan IPO to debut today. Can the stock double its issue price on listing? Jul 28, 2021 04:11 PM IST

    Tatva Chintan IPO to debut today. Can the stock double its issue price on listing?

    Tatva Chintan IPO: Experts feel the company's healthy financials with strong return ratios, diversified product portfolio, global presence with wide customer base and overwhelming response to IPO could drive up the listing price.

  • Tatva Chintan IPO share allotment finalised: How to check status Jul 27, 2021 04:25 PM IST

    Tatva Chintan IPO share allotment finalised: How to check status

    The shares of Tatva Chintan will start trading on both BSE and NSE from July 29.

  • Tatva Chintan IPO shares trade at more than 100% premium in grey market ahead of listing Jul 27, 2021 02:07 PM IST

    Tatva Chintan IPO shares trade at more than 100% premium in grey market ahead of listing

    Tatva Chintan IPO shares will make a debut on the bourses on July 29

  • Tatva Chintan IPO share allotment: Here's how to check your application status Jul 26, 2021 08:07 AM IST

    Tatva Chintan IPO share allotment: Here's how to check your application status

    Tatva Chintan IPO: The Rs 500-crore public issue received overwhelming response from investors as it was oversubscribed by 180.36 times during July 16-20, the second highest subscription in 2021 after MTAR Technologies

  • Tatva Chintan IPO: Why it attracted the second-highest subscription level among issues in 2021 Jul 21, 2021 11:35 AM IST

    Tatva Chintan IPO: Why it attracted the second-highest subscription level among issues in 2021

    Most companies are capitalising on suitable market conditions to raise equity capital at premium valuations. Tatva Chintan was no exception and investors bid for 180 times the shares that the company offered.

  • Tatva Chintan IPO subscribed 180.35 times on final day, NII portion booked 512.22 times Jul 20, 2021 11:46 AM IST

    Tatva Chintan IPO subscribed 180.35 times on final day, NII portion booked 512.22 times

    Tatva Chintan IPO: The company shares traded at a premium of Rs 700-750 in the grey market at time of writing this copy

  • Tatva Chintan IPO oversubscribed by 15.04 times on Day 2, QIB portion booked 2 times Jul 19, 2021 11:38 AM IST

    Tatva Chintan IPO oversubscribed by 15.04 times on Day 2, QIB portion booked 2 times

    The specialty chemical company opened its IPO for subscription on July 16. It was subscribed 4.5 times on the first day of bidding.

  • Tatva Chintan IPO: Parvati Rai of KRChoksey explains why the issue got fully subscribed within hours Jul 17, 2021 09:59 AM IST

    Tatva Chintan IPO: Parvati Rai of KRChoksey explains why the issue got fully subscribed within hours

    Strong financials, growth potential, dominant position and potential play on green chemistry has helped Tatva Chintan IPO garner huge interest

  • Tatva Chintan Pharma Chem IPO shares trade at 60% premium in grey market as the issue opens Jul 16, 2021 03:04 PM IST

    Tatva Chintan Pharma Chem IPO shares trade at 60% premium in grey market as the issue opens

    The specialty chemical company is planning to raise Rs 500 crore through public issue which comprises a fresh issue of Rs 225 crore and an offer for sale of Rs 275 crore by promoter and promoter group.

  • Subscribe to Tatva Chintan Pharma Chem: Hem Securities Jul 16, 2021 02:33 PM IST

    Subscribe to Tatva Chintan Pharma Chem: Hem Securities

    Hem Securities has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 15, 2021.

  • Subscribe to Tatva Chintan Pharma Chem: Motilal Oswal Jul 16, 2021 02:14 PM IST

    Subscribe to Tatva Chintan Pharma Chem: Motilal Oswal

    Motilal Oswal has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 15, 2021.

  • Subscribe to Tatva Chintan Pharma Chem: KR Choksey Jul 16, 2021 02:00 PM IST

    Subscribe to Tatva Chintan Pharma Chem: KR Choksey

    KR Choksey has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 15, 2021.

  • Subscribe to Tatva Chintan Pharma Chem: Anand Rathi Jul 16, 2021 01:53 PM IST

    Subscribe to Tatva Chintan Pharma Chem: Anand Rathi

    Anand Rathi has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 15, 2021.

  • Tatva Chintan Pharma Chem: Is the speciality chemical IPO worth applying? Jul 16, 2021 10:37 AM IST

    Tatva Chintan Pharma Chem: Is the speciality chemical IPO worth applying?

    Tatva has a diversified product portfolio, with a dominant position in most product segments. Valuations are at a discount to the comparable peer set

  • Tatva Chintan Pharma Chem IPO opens today: Should you subscribe? Jul 16, 2021 08:12 AM IST

    Tatva Chintan Pharma Chem IPO opens today: Should you subscribe?

    On account of strong growth potential, dominant manufacturer status, potential play on 'green chemistry' and discounted valuation compared to its peers, KR Choksey recommended a 'subscribe' rating for long term gains for Tatva Chintan IPO.

  • Tatva Chintan Pharma Chem mobilises Rs 150 crore from anchor investors ahead of IPO Jul 15, 2021 10:28 PM IST

    Tatva Chintan Pharma Chem mobilises Rs 150 crore from anchor investors ahead of IPO

    Axis MF, Aditya Birla Sun Life, Nippon Life, SBI Life Insurance,, SBI MF, ICICI Prudential, and HDFC Trustee are among domestic investors invested in Tatva Chintan through anchor book.

  • Tatva Chintan Pharma Chem IPO opens tomorrow, 10 key things to know about the issue Jul 15, 2021 07:46 PM IST

    Tatva Chintan Pharma Chem IPO opens tomorrow, 10 key things to know about the issue

    Promoters held 1,61,75,850 equity shares in aggregate, representing 80.53 percent of total paid up equity of Tatva Chintan.

  • Tatva Chintan Pharma Chem IPO to open on July 16; price band set at Rs 1,073-1,083 Jul 13, 2021 07:42 AM IST

    Tatva Chintan Pharma Chem IPO to open on July 16; price band set at Rs 1,073-1,083

    The company plans to raise Rs 500 crore through IPO which comprises a fresh issue of Rs 225 crore and an offer for sale of Rs 275 crore by existing selling shareholders.

  • Tatva Chintan Pharma Chem files DRHP, to raise Rs 450 crore via IPO Apr 02, 2021 06:47 PM IST

    Tatva Chintan Pharma Chem files DRHP, to raise Rs 450 crore via IPO

    The initial public offer comprises fresh issuance of equity shares worth Rs 225 crore and an offer of sale to the tune of Rs 225 crore by existing promoters and shareholders.

Sections
ISO 27001 - BSI Assurance Mark